Eric Hall Overview

  • Primary Position
  • Partner

  • Primary Industry
  • Healthcare

  • Med. Deal Size

  • Med. Valuation

Eric Hall General Information

Biography

Mr. Hall serves as Partner at FLG Partners. He joined FLG in 2004 and presently sits on the Firm's Management Committee. He served as Interim Chief Financial Officer, Secretary and Principal Financial Officer at RAPT Therapeutics. Mr. Eric Hall serves as Chief Financial Officer at Gradalis. Eric Hall, CFA, joined Gradalis as Chief Financial Officer in January 2023, after serving as interim CFO since August 2023. Eric has over 30 years of experience serving as Chief Financial Officer and Chief Operating Officer for a variety of public and private companies. For the past18 years, Mr. Hall has been a Partner of FLG Partners, LLC and a member of their Management Committee. He has extensive global experience in finance and has raised over $3 billion in debt and equity financing. He has been interim CFO for multiple life science companies, and since 2019, he has helped RAPT Therapeutics, ALX Oncology, Connect Biopharma, and Elevation Oncology in their IPOs. Mr. Hall is a Chartered Financial Analyst and member of the CFA Institute and the CFA Society of San Francisco. He has an MBA in Finance from the Owen Graduate School of Management, Vanderbilt University, and a B.A. in Economics from the University of California at Davis. Eric has over 25 years of experience serving as President, Chief Operating Officer, and Chief Financial Officer for a variety of public and private companies. He has extensive experience in finance, venture capital, banking, treasury and investment management, strategic planning, mergers and acquisitions, operations, and real estate. Eric has experience in building successful financial organizations in companies from the ground up. He has helped launch several Internet companies over the past years as CFO for The ImagiNation Network, Yahoo!, women.com and NetChannel. Prior to joining FLG, Eric was a partner and CFO of McKenna Capital LLC/mc3 ventures, an early stage venture capital fund located in San Francisco, California. He was actively involved in the investment decisions and follow-on management of McKenna Capital's portfolio companies. As a board member of two of McKenna Capital's companies he is experienced in the changing issues and challenges regarding corporate governance. Earlier in his career, Eric focused on providing interim COO/CFO services and strategic planning assignments for over 30 clients ranging from Fortune 500 to venture-backed companies. Previously, Eric was Founder and CEO of the Archer Group, Partner at Technology Perspectives, Partner at David Powell - FSD, Vice President/Portfolio Manager for Wells Fargo Bank, Principal Planner and Domestic and International Treasury Manager for Amdahl Corporation, and Senior Consultant for Arthur Andersen & Co. Eric has an MBA in Finance from the Owen Graduate School of Management at Vanderbilt University, and a BA in Economics from the University of California, Davis. He is also a Chartered Financial Analyst and member of the CFA Institute. Mr. Hall served as the Venture Partner at McKenna Capital. He also serves as Interim Chief Financial Officer at Elevation Oncology.

Contact Information

Primary Position
Partner, FLG Partners
Education
Vanderbilt University, MBA (Master of Business Administration)
University of California, Davis, BA (Bachelor of Arts)
Gender
Male
Email
er
Phone
+1 (415)
Address
  • 228 Hamilton Avenue
  • Third Floor
  • Palo Alto, CA 94301
  • United States

Eric Hall Positions (3)

Firm name Firm type Title Location Industry Since
Elevation Oncology Company Interim Chief Financial Officer New York, NY Drug Discovery
FLG Partners Service Provider Partner Palo Alto, CA Financing Advisory
Gradalis Company Chief Financial Officer Carrollton, TX Drug Discovery

Eric Hall Lead Partner on Deals (2)

Eric Hall has been the lead partner on 2 deals. Their latest deal was with Elevation Oncology, a drug discovery company. The deal was made for on 25-Jun-2021.

Company Deal Date Deal Type Deal Size Deal Status Industry Location
Elevation Oncology 25-Jun-2021 IPO Completed Drug Discovery New York, NY
Connect Biopharmaceuticals 19-Mar-2021 Completed Drug Discovery Taicang, China

Eric Hall Network (14)

Portfolio Executives (14)

Name Company Role Deal date Location
David Dornan Ph.D Elevation Oncology Chief Scientific Officer 25-Jun-2021 New York, NY
David Dornan Ph.D Elevation Oncology Chief Scientific Officer 25-Jun-2021 New York, NY
Elevation Oncology Chief Executive Officer & Board Member 25-Jun-2021 New York, NY
Elevation Oncology Chief Financial Officer, Finance & Chief Accounting Officer, Accounting 25-Jun-2021 New York, NY
Elevation Oncology Chief Executive Officer & Board Member 25-Jun-2021 New York, NY

Eric Hall FAQs

  • Who is Eric Hall?

    Mr. Hall serves as Partner at FLG Partners.

  • How much does Eric Hall typically invest?

    Eric Hall's median deal size is .

  • What is Eric Hall’s main position?

    Eric Hall’s primary position is Partner.

  • What are the contact details for Eric Hall?

    Eric Hall’s email address is er and his phone number is +1 (415) .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »